445Tip VIVA Trial: A Randomized Phase II Study of Adjuvant Regorafenib Plus Durvalumab in Stage IV Colorectal Cancer Patients Achieving the No Evidence of Disease State
Annals of Oncology（2022）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined